RNXT CIK: 1574094

RenovoRx, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
7.27
FY23:
1.47
FY24:
7.83
FY25:
7.89
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0
FY23:
0
FY24:
0.29
FY25:
0.20
Total assets
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
7.27
FY23:
1.47
FY24:
8.12
FY25:
8.10

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.94
FY22:
1.10
FY23:
1.18
FY24:
1.91
FY25:
1.96
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
3.29
FY24:
1.73
FY25:
0.71
(positive)
Change from FY21 to FY25
millions USD
FY21:
15.3
FY22:
6.16
FY23:
−3.00
FY24:
4.48
FY25:
5.42
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
7.27
FY23:
1.47
FY24:
8.12
FY25:
8.10

All amounts in millions USD Data source:SEC EDGAR